| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |